Editas Medicine, Inc. (EDIT)

3.08 +0.32 (+11.59%) USD  |  NASDAQ  |  May 26, 16:00
3.32 +0.24 (+7.79%) Pre-Market: 08:08
More

Editas Medicine Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for EDIT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Puma Biotechnology, Inc. Upgrade
Precision BioSciences, Inc. Upgrade
Black Diamond Therapeutics, Inc. Upgrade